About Amaxa Nucleofector Transfection Technology
Amaxa Nucleofector Transfection Technology- Non-viral gene transfer directly into the nucleus of primary cells and cell lines, providing rapid target gene validation, acceleration of drug development and new applications for gene therapy - by Lonza Group Ltd.
